IXJ vs. SBIO
IXJ (iShares Global Healthcare ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both Health & Biotech Equities funds - IXJ tracks the S&P Global Healthcare Sector Index while SBIO tracks the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 10 years, IXJ returned 7.66%/yr vs 8.02%/yr for SBIO. A 0.57 correlation means they provide meaningful diversification when combined. IXJ charges 0.46%/yr vs 0.50%/yr for SBIO.
Performance
IXJ vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IXJ achieves a -5.26% return, which is significantly lower than SBIO's -0.39% return. Both investments have delivered pretty close results over the past 10 years, with IXJ having a 7.66% annualized return and SBIO not far ahead at 8.02%.
IXJ
- 1D
- 0.39%
- 1M
- 0.34%
- YTD
- -5.26%
- 6M
- -4.88%
- 1Y
- 9.30%
- 3Y*
- 4.42%
- 5Y*
- 4.02%
- 10Y*
- 7.66%
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
IXJ vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | -5.26% | 14.99% | 0.55% | 3.62% | -4.94% | 19.60% | 12.74% | 23.23% | 2.83% | 20.44% |
SBIO ALPS Medical Breakthroughs ETF | -0.39% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between IXJ and SBIO is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.55 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.57 |
The correlation between IXJ and SBIO has been stable across timeframes, ranging from 0.48 to 0.57 - a consistent structural relationship.
IXJ vs. SBIO - Sectors Allocation Comparison
Sectors
IXJ
SBIO
Healthcare
Consumer Defensive
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IXJ
SBIO
Consumer Defensive
IXJ
SBIO
-
Basic Materials
IXJ
-
SBIO
-
Communication Services
IXJ
-
SBIO
-
Consumer Cyclical
IXJ
-
SBIO
-
Energy
IXJ
-
SBIO
-
Financial Services
IXJ
-
SBIO
Industrials
IXJ
-
SBIO
-
Real Estate
IXJ
-
SBIO
-
Technology
IXJ
-
SBIO
-
Utilities
IXJ
-
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. SBIO — Risk / Return Rank
IXJ
SBIO
IXJ vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | SBIO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | 2.24 | -1.60 |
Sortino ratioReturn per unit of downside risk | 1.06 | 3.10 | -2.04 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.36 | -0.24 |
Calmar ratioReturn relative to maximum drawdown | 0.87 | 5.19 | -4.33 |
Martin ratioReturn relative to average drawdown | 2.11 | 15.57 | -13.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IXJ | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 2.24 | -1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.08 | +0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.24 | +0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.21 | +0.20 |
Drawdowns
IXJ vs. SBIO - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for IXJ and SBIO.
Loading charts...
Drawdown Indicators
| IXJ | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -63.06% | +22.46% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | -12.66% | +1.88% |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | -42.44% | +24.30% |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | -53.10% | +34.96% |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | -63.06% | +35.71% |
Current DrawdownCurrent decline from peak | -9.27% | -16.79% | +7.52% |
Average DrawdownAverage peak-to-trough decline | -6.92% | -28.45% | +21.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 4.22% | +0.19% |
Volatility
IXJ vs. SBIO - Volatility Comparison
The current volatility for iShares Global Healthcare ETF (IXJ) is 3.75%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.48%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IXJ | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | 9.48% | -5.73% |
Volatility (6M)Calculated over the trailing 6-month period | 10.05% | 22.70% | -12.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.55% | 29.42% | -14.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 33.56% | -19.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.67% | 33.17% | -17.50% |
IXJ vs. SBIO - Expense Ratio Comparison
IXJ has a 0.46% expense ratio, which is lower than SBIO's 0.50% expense ratio.
Dividends
IXJ vs. SBIO - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.47%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | 1.47% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Frequently Asked Questions
IXJ and SBIO have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.48%) compared to IXJ (3.75%). In terms of maximum drawdown, IXJ dropped -40.60% vs SBIO's -63.06%.
On 10-year performance, SBIO leads with 8.02% vs 7.66% for IXJ. On fees, IXJ is cheaper at 0.46% per year. On volatility, IXJ has been the lower-risk option at 3.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SBIO has performed better with a 8.02% return vs 7.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IXJ is cheaper with a 0.46% expense ratio, compared with 0.50% for SBIO.
IXJ has the higher dividend yield at 1.47%, compared with 0.00% for SBIO.
IXJ tracks S&P Global Healthcare Sector Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: iShares and SS&C. Their fees differ too: 0.46% for IXJ and 0.50% for SBIO.
SBIO currently has the higher Sharpe Ratio (2.24 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IXJ and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer